SCHEMBL4903014

SCHEMBL4903014

CCN(c1coc(C2CCCCC2)n1)S(=O)(=O)c1ccc(C)c(C(=O)O)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.40
GAA P10253 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TSHR P16473 4/20 0.38
KDM4E B2RXH2 2/20 0.38
NPSR1 Q6W5P4 1/20 0.37
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
ESR1 P03372 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900736 0.90 TSHR (0.39) LMNAGAAALDH1A1TSHRKDM4E
SCHEMBL4897582 0.76 LMNA (0.40) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4903003 0.75 LMNA (0.49) LMNAGAAALDH1A1ALOX15TSHR
SCHEMBL4906508 0.75 LMNA (0.41) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4906638 0.71 ALDH1A1 (0.44) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4903050 0.70 STAT3 (0.43) GAATSHRKDM4E
SCHEMBL5922617 0.70 KDM4E (0.46) LMNAGAAALDH1A1ALOX15TSHR
SCHEMBL4899849 0.69 LMNA (0.46) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4906585 0.69 LMNA (0.43) LMNAGAAALDH1A1HPGDALOX15
SCHEMBL4906525 0.68 LMNA (0.47) LMNAALDH1A1HPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885GAA 1367/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885GAA 1367/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.